Reduce anxiety and improve functioning
- Trial ID
- NCT07310147
- Official Title
- Empower Your Mind to Embrace Your Life: Development and Efficacy Study of a Videoconference-delivered Group Intervention Based on Acceptance and Commitment Therapy for People With Young-onset Parkinson's Disease
- Goal
- Reduce anxiety and improve functioning
- Phase
- NA
- Status
- RECRUITING
- Sponsor
- University of Coimbra
- Study Type
- INTERVENTIONAL
- Enrollment
- 20 participants
- Conditions
- Parkinson's Disease (PD)
- Interventions
- Empower your mind to embrace your life
Plain-Language Summary
Aiming to help people with young-onset Parkinson's manage distress, anxiety, and loss of everyday functioning by increasing psychological flexibility and overall quality of life. It offers a group Acceptance and Commitment Therapy program delivered by videoconference, teaching acceptance of difficult thoughts and sensations, mindfulness, and committed, values-driven action; as a talk-based therapy it complements usual Parkinson's medications like levodopa and does not change how those drugs work. Looking for Portuguese-speaking adults 21 to 65 years old with neurologist-confirmed young-onset PD in Hoehn and Yahr stages 1 to 2.5, and excludes those currently in psychological treatment, pregnant people, anyone with current suicidal ideation, severe psychiatric illness, or cognitive impairment.
Locations
- CINEICC, Coimbra, Portugal
Frequently Asked Questions
- What is this trial testing?
- This trial is studying Empower your mind to embrace your life. Aiming to help people with young-onset Parkinson's manage distress, anxiety, and loss of everyday functioning by increasing psychological flexibility and overall quality of life. It offers a group Acceptance and Commitment Therapy program delivered by videoconference, teaching acceptance of difficult thoughts and sensations, mindfulness, and committed, values-driven action; as a talk-based therapy it complements usual Parkinson's medications like levodopa and does not change how those drugs work. Looking for Portuguese-speaking adults 21 to 65 years old with neurologist-confirmed young-onset PD in Hoehn and Yahr stages 1 to 2.5, and excludes those currently in psychological treatment, pregnant people, anyone with current suicidal ideation, severe psychiatric illness, or cognitive impairment.
- Who can participate?
- Participants must be between 21 Years and 65 Years.
- Where is this trial located?
- This trial is recruiting at 1 location.
- Does it cost anything to join?
- No. There is no cost to participate. Study-related care and treatment are provided at no charge.
- How long does the trial last?
- This trial is estimated to last approximately 1 year and 3 months.